New chapter in Australia China health industry exchange: Shenzhen Rennan Group and Homart Group explore new cooperation opportunities together

Recently, Dr. Chen Jianchao, President of the Australian Chinese Medicine Chamber of Commerce and President of Shenzhen Rennan Group in Australia, visited the well-known Homart Group in Australia to have in-depth exchanges with the Group Chairman Ye Beiling on production cooperation matters. This interaction injected new vitality into the cooperation between China and Australia in the health industry.

As the President of Shenzhen Rennan Group in Australia, I shoulder the responsibility of promoting the expansion of Rennan Group in the Australian market. Under the leadership of Chairman Ye Beiling, Homart Group has become a leading enterprise in the Australian health industry. Its products are exported to more than 60 countries and regions around the world, covering various fields such as big health, beauty care, maternal and child nutrition, and pet health. It has achieved significant results in the international market, especially in the Chinese market.

During the exchange, both parties had in-depth discussions on the research and development, production, and market promotion of traditional Chinese medicine products and natural health products. Dr. Chen Jianchao shared the research and development achievements and rich experience of Shenzhen Rennan Group in the field of traditional Chinese medicine, especially mentioning that the products of Rennan Group use traditional Chinese medicine and plants as safe natural raw materials, covering disinfection and sterilization, equipment, cosmetics, human and pet daily chemicals and other series. These products combine advanced production technology and strict quality control system. Chairman Ye Beiling introduced Homart Group's modern production facilities and mature global sales network, emphasizing the group's advantages in health products, personal care products and other fields, as well as its persistent pursuit of quality.

Both sides agree that China and Australia have strong complementarity in the health industry and broad prospects for cooperation. This exchange has laid a solid foundation for future cooperation between the two parties in product research and development, production collaboration, and market expansion. In the future, Shenzhen Rennan Group and Homart Group are expected to integrate their resources to develop more health products that meet global market demand. This will not only promote the dissemination and application of traditional Chinese medicine in Australia and even globally, but also further deepen cooperation between China and Australia in the field of health industry, making positive contributions to the economic development and public health and well-being of both countries.

Homart Manager Livia introduces your group's certification certificate

This exchange activity is another important milestone in the cooperation between China and Australia in the health industry, indicating that both sides will work together to take more solid steps in the global health market and jointly create a new situation for the development of the health industry.